Launch and Postlaunch Price Developments of New Drugs in the US, Germany, and Switzerland

Authors:

Abstract
High prices of new drugs are concerning worldwide. In the US, overall drug spending between 2021 and 2022 grew by 9.4%, with a total of approximately $635.5 billion in 2022.1 Similar trends can be observed in European countries. For example, in Germany and Switzerland, drug expenditure increased by 5.2% and 6.5%, respectively, between 2021 and 2022.2,3 Drug prices are associated with these increasing costs.4

This publication has 16 references indexed in Scilit: